Terms: = Gastric cancer AND CEACAM5, CEA AND Diagnosis
389 results:
1. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
2. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
3. A case report of carcinoma of the papilla of Vater associated with a hyperplasia-dysplasia-carcinoma sequence by pancreaticobiliary maljunction.
Korai T; Kimura Y; Watanabe K; Low SK; Imamura M; Nagayama M; Kukita K; Murakami T; Kato T; Kondo Y; Kyuno D; Sugawara T; Murota A; Kawakami Y; Masaki Y; Nakase H; Takemasa I
World J Surg Oncol; 2024 Feb; 22(1):63. PubMed ID: 38389074
[TBL] [Abstract] [Full Text] [Related]
4. Potential clinical significance of ALDH3B1 in auxiliary diagnosis of gastric cancer.
Tang C; Xu J; Zheng M; Qian D; Gao Z; Li X; Zhang W
Biomark Med; 2024 Jan; 18(1):15-23. PubMed ID: 38334412
[No Abstract] [Full Text] [Related]
5. Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer.
Li J; Chen Z; Li Q; Liu R; Zheng J; Gu Q; Xiang F; Li X; Zhang M; Kang X; Wu R
PeerJ; 2024; 12():e16660. PubMed ID: 38259671
[TBL] [Abstract] [Full Text] [Related]
6. Robust Glycoproteomics Platform Reveals a Tetra-Antennary Site-Specific Glycan Capping with Sialyl-Lewis Antigen for Early Detection of gastric cancer.
Liu L; Liu L; Wang Y; Fang Z; Bian Y; Zhang W; Wang Z; Gao X; Zhao C; Tian M; Liu X; Qin H; Guo Z; Liang X; Dong M; Nie Y; Ye M
Adv Sci (Weinh); 2024 Mar; 11(9):e2306955. PubMed ID: 38084450
[TBL] [Abstract] [Full Text] [Related]
7. The Leser-Trélat Sign in a Patient with gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
8. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
9. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
10. Application of serum gastric function markers and digestive tumor indices to the diagnosis of early gastric cancer and precancerous lesions.
Yanan Z; Juan W; Jun W; Xin M; Kejian W; Fangyu W
Saudi Med J; 2023 Aug; 44(8):795-800. PubMed ID: 37582570
[TBL] [Abstract] [Full Text] [Related]
11. Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (cea) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
Kiio LK; Onyatta JO; Ndangili PM; Oloo F; Santamaria C; Montuenga LM; Mbui DN
Talanta; 2024 Jan; 266(Pt 1):124934. PubMed ID: 37454512
[TBL] [Abstract] [Full Text] [Related]
12. Ribosomal DNA copy number alteration in blood sample from gastric cancer patients.
Chen C; Feng L; Chen J; Shen J; Lin L
Mol Biol Rep; 2023 Sep; 50(9):7155-7160. PubMed ID: 37407803
[TBL] [Abstract] [Full Text] [Related]
13. Catalytic hairpin assembly-assisted dual-signal amplification platform for ultrasensitive detection of tumor markers and intelligent diagnosis of gastric cancer.
Gao R; Ji R; Dong W
Talanta; 2023 Dec; 265():124812. PubMed ID: 37327666
[TBL] [Abstract] [Full Text] [Related]
14. Ultrasensitive detection of gastric cancer biomarkers
Huang Y; Liu Z; Qin X; Liu J; Yang Y; Wei W
Analyst; 2023 Jul; 148(14):3295-3305. PubMed ID: 37318011
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of influencing factors of nerve invasion in locally advanced gastric cancer.
Ren XC; Liang P
Abdom Radiol (NY); 2023 Sep; 48(9):3005-3011. PubMed ID: 37289214
[TBL] [Abstract] [Full Text] [Related]
16. CircRNA
Li R; Tian X; Jiang J; Qian H; Shen H; Xu W
Biomarkers; 2023 Dec; 28(5):448-457. PubMed ID: 37128800
[TBL] [Abstract] [Full Text] [Related]
17. The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.
Roșu MC; Ardelean A; Moldovan SD; Faur FI; Nesiu A; Totoloci BD
J Med Life; 2023 Feb; 16(2):186-188. PubMed ID: 36937484
[TBL] [Abstract] [Full Text] [Related]
18. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers.
Liu HN; Yao C; Wang XF; Zhang NP; Chen YJ; Pan D; Zhao GP; Shen XZ; Wu H; Liu TT
World J Gastroenterol; 2023 Jan; 29(4):706-730. PubMed ID: 36742169
[TBL] [Abstract] [Full Text] [Related]
20. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
Wang SS; Guo ZP; Zhao XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
[TBL] [Abstract] [Full Text] [Related]
[Next]
